Insider · CIK 0001520265

Fitzpatrick Mark J.

Reports to the SEC for 3 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001520265

Forms 4 and 5

Insider transactions

45 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-04-06	Allena Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+74K sh	—	—	74,000
2020-12-04	CHIASMA, INCM Exercise/Conversion	President	MExercise/Conversion	+10K sh	$2.60	+$26K	19,612
2020-12-04	CHIASMA, INCStock Option (Right to Buy)M Exercise/Conversion	President	MExercise/Conversion	−10K sh	—	—	363,352
2020-02-14	CHIASMA, INCStock Option (Right to Buy)A Award	President	AAward	+150K sh	—	—	150,000
2019-02-14	CHIASMA, INCStock Option (Right to Buy)A Award	President	AAward	+186K sh	—	—	186,000
2018-12-20	CHIASMA, INCP Purchase	President	PPurchase	+9,612 sh	$2.50	+$24K	9,612
2018-02-23	CHIASMA, INCStock Option (Right to Buy)A Award	President	AAward	+68K sh	—	—	67,967
2018-02-23	CHIASMA, INCStock Option (Right to Buy)A Award	President	AAward	+194K sh	—	—	194,183
2016-10-25	CHIASMA, INCStock Option (right to buy)A Award	President	AAward	+373K sh	—	—	373,352
2016-02-10	CHIASMA, INCStock Option (right to buy)A Award	President	AAward	+70K sh	—	—	70,000
2015-04-01	Aegerion Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+10K sh	—	—	10,000
2015-04-01	Aegerion Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+40K sh	—	—	40,000
2014-12-31	Aegerion Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+65K sh	—	—	65,000
2014-08-19	Aegerion Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+1,150 sh	$30.64	+$35.2K	9,500
2014-03-04	Aegerion Pharmaceuticals, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+2,500 sh	$17.64	+$44.1K	8,350
2014-03-04	Aegerion Pharmaceuticals, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−2,500 sh	—	—	189,650
2014-02-10	Aegerion Pharmaceuticals, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+7,500 sh	$17.64	+$132K	13,350
2014-02-10	Aegerion Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−3,300 sh	$61.71	−$204K	10,050
2014-02-10	Aegerion Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−2,814 sh	$62.94	−$177K	7,236
2014-02-10	Aegerion Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−900 sh	$63.72	−$57.3K	6,336
2014-02-10	Aegerion Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−486 sh	$64.69	−$31.4K	5,850
2014-02-10	Aegerion Pharmaceuticals, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−7,500 sh	—	—	192,150
2013-11-18	Aegerion Pharmaceuticals, Inc.G Gift	Chief Financial Officer	GGift	−100 sh	—	—	5,750
2013-11-18	Aegerion Pharmaceuticals, Inc.G Gift	Chief Financial Officer	GGift	+100 sh	—	—	100
2013-11-13	Aegerion Pharmaceuticals, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−2,850 sh	—	—	199,650
2013-11-11	Aegerion Pharmaceuticals, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−7,500 sh	—	—	202,500
2013-11-11	Aegerion Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−200 sh	$73.01	−$14.6K	10,300
2013-11-11	Aegerion Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−200 sh	$74.43	−$14.9K	10,100
2013-11-11	Aegerion Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−200 sh	$76.14	−$15.2K	9,900
2013-11-11	Aegerion Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−622 sh	$78.38	−$48.8K	9,278
2013-11-11	Aegerion Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−4,478 sh	$79.34	−$355K	4,800
2013-11-11	Aegerion Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−1,800 sh	$80.03	−$144K	3,000
2013-11-11	Aegerion Pharmaceuticals, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+2,850 sh	$17.64	+$50.3K	5,850
2013-11-11	Aegerion Pharmaceuticals, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+7,500 sh	$17.64	+$132K	10,500
2013-08-26	Aegerion Pharmaceuticals, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−2,500 sh	—	—	210,000
2013-08-26	Aegerion Pharmaceuticals, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+2,500 sh	$17.64	+$44.1K	3,000
2013-08-14	Aegerion Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−588 sh	$94.44	−$55.5K	500
2013-08-14	Aegerion Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−2,512 sh	$92.74	−$233K	5,488
2013-08-14	Aegerion Pharmaceuticals, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+7,500 sh	$17.64	+$132K	8,000
2013-08-14	Aegerion Pharmaceuticals, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−7,500 sh	—	—	212,500
2013-08-14	Aegerion Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−4,400 sh	$93.71	−$412K	1,088
2013-04-01	Aegerion Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+27.5K sh	—	—	27,500
2012-03-23	Aegerion Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+200 sh	$14.16	+$2,831.8	200
2012-03-23	Aegerion Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+300 sh	$14.15	+$4,244.4	500
2011-06-01	Aegerion Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	−220K sh	—	—	220,000

Recent filings

Accepted (ET)
Apr 84
Fitzpatrick Mark J.0000899243-21-015383
SEC(opens sec.gov)
Dec 74
Fitzpatrick Mark J.0001209191-20-061949
SEC(opens sec.gov)
Feb 184
Fitzpatrick Mark J.0001209191-20-010043
SEC(opens sec.gov)
Feb 154
Fitzpatrick Mark J.0001209191-19-010646
SEC(opens sec.gov)
Dec 214
Fitzpatrick Mark J.0001209191-18-063832
SEC(opens sec.gov)
Feb 264
Fitzpatrick Mark J.0001209191-18-013680
SEC(opens sec.gov)
Oct 254
CHIASMA, INC0000899243-16-032282
SEC(opens sec.gov)
Feb 124
CHIASMA, INC0000899243-16-013241
SEC(opens sec.gov)
Apr 34
Aegerion Pharmaceuticals, Inc.0001209191-15-032415
SEC(opens sec.gov)
Jan 54
Aegerion Pharmaceuticals, Inc.0001209191-15-001608
SEC(opens sec.gov)
Aug 204
Aegerion Pharmaceuticals, Inc.0001209191-14-053601
SEC(opens sec.gov)
Mar 54
Aegerion Pharmaceuticals, Inc.0001209191-14-017598
SEC(opens sec.gov)
Feb 124
Aegerion Pharmaceuticals, Inc.0001209191-14-009634
SEC(opens sec.gov)

Companies

Address

C/O/ AEGERION PHARMACEUTICALS, INC. 101 MAIN STREET, STE 1850

CAMBRIDGE, MA, 02142